Compare Paycom Software Inc (PAYC) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paycom Software Inc vs Vaxcyte Inc. Common Stock — how do they compare? Paycom Software Inc trades at $238.6 (market cap $10.67B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Paycom Software Inc and Vaxcyte Inc. Common Stock are close in size by market cap, and Paycom Software Inc pays a 0.63% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Paycom Software Inc for 84 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| PAYC | PCVX | |
|---|---|---|
Market Cap | $10.67B | $10.51B |
Volume | 411,289 | 2,644,694 |
Sector | Technology | Health |
52-Week High | $240.52 | $73.82 |
52-Week Low | $113.59 | $40.32 |
Typical Hold Time | 84 Days | 0 Days |
Enterprise Value | $11.45B | $9.14B |
Dividend Yield | 0.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PAYC trades at $239.00, up 1.7% today, with a bullish technical trend and strong fundamentals. The company reported Q2 2026 EPS of $2.78, beating estimates by 17%, and raised full-year guidance to 7-8% revenue growth. Valuation metrics show a P/E of 25.04 and robust profitability with a net margin of 22.78%. Recent news highlights institutional buying and positive earnings momentum.
The outlook is positive given earnings beats and raised guidance, but risks include high valuation multiples and competitive pressures. Analysts are mixed with a $211.08 consensus target, below the current price, suggesting cautious optimism. The stock's proximity to its 52-week high warrants monitoring for pullbacks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
